Nancy Olashaw

3.5k total citations · 1 hit paper
39 papers, 2.9k citations indexed

About

Nancy Olashaw is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nancy Olashaw has authored 39 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Nancy Olashaw's work include NF-κB Signaling Pathways (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Nancy Olashaw is often cited by papers focused on NF-κB Signaling Pathways (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Nancy Olashaw collaborates with scholars based in United States, Chile and Georgia. Nancy Olashaw's co-authors include W. J. Pledger, Edward Seto, Xiaohong Zhang, Zhigang Yuan, William S. Lane, John M. Koomen, Sue Goo Rhee, Jie Wu, Jiandong Chen and Matthew I. Wahl and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Nancy Olashaw

39 papers receiving 2.8k citations

Hit Papers

HDAC6 Modulates Cell Motility by Altering the Acetylation... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers

Nancy Olashaw
Ron Firestein United States
Yonghua Yang United States
Peggie Cheung United States
Michele A. Glozak United States
Chia‐Hsin Chan United States
Olga Chernova United States
Anatoly Nikolaev United States
N. Shaun B. Thomas United Kingdom
Nancy Olashaw
Citations per year, relative to Nancy Olashaw Nancy Olashaw (= 1×) peers Alida M.M. de Vries-Smits

Countries citing papers authored by Nancy Olashaw

Since Specialization
Citations

This map shows the geographic impact of Nancy Olashaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Olashaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Olashaw more than expected).

Fields of papers citing papers by Nancy Olashaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Olashaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Olashaw. The network helps show where Nancy Olashaw may publish in the future.

Co-authorship network of co-authors of Nancy Olashaw

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Olashaw. A scholar is included among the top collaborators of Nancy Olashaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Olashaw. Nancy Olashaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Huiqin, Xiaoling Li, Nancy Olashaw, et al.. (2008). Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene. 28(3). 445–460. 175 indexed citations
2.
Zhang, Xiaohong, Zhigang Yuan, Yingtao Zhang, et al.. (2007). HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin. Molecular Cell. 27(2). 197–213. 588 indexed citations breakdown →
3.
Yang, Yonghua, Wei Fu, Jiandong Chen, et al.. (2007). SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nature Cell Biology. 9(11). 1253–1262. 265 indexed citations
4.
Zhang, Xiaohong, et al.. (2004). Molecular Cloning and Functional Characterization of the Transcription Factor YY2. Journal of Biological Chemistry. 279(24). 25927–25934. 55 indexed citations
5.
Epling‐Burnette, Pearlie K., Fanqi Bai, Sheng Wei, et al.. (2004). ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene. 23(57). 9220–9229. 61 indexed citations
6.
Landowski, Terry H., Nancy Olashaw, Deepak Agrawal, & William S. Dalton. (2003). Cell adhesion-mediated drug resistance (CAM-DR) is associated with activation of NF-κB (RelB/p50) in myeloma cells. Oncogene. 22(16). 2417–2421. 149 indexed citations
7.
Olashaw, Nancy & W. J. Pledger. (2002). Paradigms of Growth Control: Relation to Cdk Activation. Science s STKE. 2002(134). re7–re7. 46 indexed citations
8.
Liu, Richard Y., Chun Fan, Guoqing Liu, Nancy Olashaw, & Kenneth S. Zuckerman. (2000). Activation of p38 Mitogen-activated Protein Kinase Is Required for Tumor Necrosis Factor-α-supported Proliferation of Leukemia and Lymphoma Cell Lines. Journal of Biological Chemistry. 275(28). 21086–21093. 66 indexed citations
9.
Liu, Richard Y., et al.. (1999). Tumor Necrosis Factor-α-induced Proliferation of Human Mo7e Leukemic Cells Occurs via Activation of Nuclear Factor κB Transcription Factor. Journal of Biological Chemistry. 274(20). 13877–13885. 25 indexed citations
10.
Hu, Xiaotang, et al.. (1999). TNF-α-Induced Growth Suppression of CD34+ Myeloid Leukemic Cell Lines Signals Through TNF Receptor Type I and Is Associated with NF-κB Activation. The Journal of Immunology. 163(6). 3106–3115. 23 indexed citations
11.
Azizan, Azliyati, et al.. (1998). Transactivation by expression of the hepatitis B virus X protein with an inducible system. Molecular Biology Reports. 25(4). 231–236. 1 indexed citations
12.
Olashaw, Nancy, et al.. (1995). Participation of Reactive Oxygen Species in the Lysophosphatidic Acid-stimulated Mitogen-activated Protein Kinase Kinase Activation Pathway. Journal of Biological Chemistry. 270(48). 28499–28502. 160 indexed citations
13.
Coats, Steve, Nancy Olashaw, & W. J. Pledger. (1994). Characterization of platelet-derived growth factor alpha receptor synthesis and metabolic turnover.. PubMed. 5(9). 937–42. 6 indexed citations
14.
Olashaw, Nancy, Timothy F. Kowalik, Eng‐Shang Huang, & W. J. Pledger. (1992). Induction of NF-kappa B-like activity by platelet-derived growth factor in mouse fibroblasts.. Molecular Biology of the Cell. 3(10). 1131–1139. 33 indexed citations
15.
Winston, Jeffrey, Nancy Olashaw, & W. J. Pledger. (1991). Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid. Journal of Cellular Biochemistry. 47(1). 79–89. 5 indexed citations
17.
Olashaw, Nancy, Judson J. Van Wyk, & W. J. Pledger. (1987). Control of late G0/G1 progression and protein modification by SmC/IGF I. American Journal of Physiology-Cell Physiology. 253(4). C575–C579. 34 indexed citations
18.
Olashaw, Nancy & W. J. Pledger. (1983). Association of platelet-derived growth factor-induced protein with nuclear material. Nature. 306(5940). 272–274. 34 indexed citations
19.
Leof, Edward B., Nancy Olashaw, W. J. Pledger, & Edward J. O’Keefe. (1982). Cyclic AMP potentiates down regulation of epidermal growth factor receptors by platelet-derived growth factor. Biochemical and Biophysical Research Communications. 109(1). 83–91. 22 indexed citations
20.
Rovera, G, Nancy Olashaw, & Pacifico Meo. (1980). Terminal differentiation in human promyelocytic leukaemic cells in the absence of DNA synthesis. Nature. 284(5751). 69–70. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026